Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom
Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.1607
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2014
Authors
Publisher
Elsevier BV